Jonathan Chauvin
Antony, 92160, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Correction: Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Journal: British journal of cancer
Published: January 20, 2026
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Journal: British journal of cancer
Published: September 28, 2023
Relation between Plasma Trough Concentration of Pazopanib and Progression-Free Survival in Metastatic Soft Tissue Sarcoma Patients.
Journal: Pharmaceutics
Published: May 03, 2022
Adaptive dosing of sunitinib in a metastatic renal cell carcinoma patient: when in silico modeling helps to go quicker to the point.
Journal: Cancer chemotherapy and pharmacology
Published: October 11, 2021
Estradiol Regulates mRNA Levels of Estrogen Receptor Beta 4 and Beta 5 Isoforms and Modulates Human Granulosa Cell Apoptosis.
Journal: International journal of molecular sciences
Published: April 13, 2021
Clinical-Based vs. Model-Based Adaptive Dosing Strategy: Retrospective Comparison in Real-World mRCC Patients Treated with Sunitinib.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: April 05, 2021
A novel method based on unbiased correlations tests for covariate selection in nonlinear mixed effects models: The COSSAC approach.
Journal: CPT: pharmacometrics & systems pharmacology
Published: November 23, 2020
Efficient Pharmacokinetic Modeling Workflow With the MonolixSuite: A Case Study of Remifentanil.
Journal: CPT: pharmacometrics & systems pharmacology
Published: September 20, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026